SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
BMS is moving beyond conversational AI into what it describes as “agentic” systems
The development comes as stroke remains one of the world’s biggest health threats
The company’s revenue stood at Rs. 287.68 crore, reflecting a 4.7 percent increase over Rs. 274.71 crore reported in FY25
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
Subscribe To Our Newsletter & Stay Updated
